Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts
Crossref DOI link: https://doi.org/10.1186/s12885-017-3404-4
Published Online: 2017-06-12
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gaustad, Jon-Vidar
Simonsen, Trude G.
Andersen, Lise Mari K.
Rofstad, Einar K.
Funding for this research was provided by:
Kreftforeningen
Helse Sør-Øst RHF